CN1186056C - medicine for treating hyperosteogeny - Google Patents
medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1186056C CN1186056C CNB021195552A CN02119555A CN1186056C CN 1186056 C CN1186056 C CN 1186056C CN B021195552 A CNB021195552 A CN B021195552A CN 02119555 A CN02119555 A CN 02119555A CN 1186056 C CN1186056 C CN 1186056C
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- rhizoma
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 206010005963 Bone formation increased Diseases 0.000 title abstract description 8
- 241000218176 Corydalis Species 0.000 claims abstract description 4
- 244000070010 Erythrina variegata Species 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000010356 tongguan Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 abstract description 3
- 208000008035 Back Pain Diseases 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 201000005569 Gout Diseases 0.000 abstract description 2
- 208000008930 Low Back Pain Diseases 0.000 abstract description 2
- 206010034464 Periarthritis Diseases 0.000 abstract description 2
- 208000008765 Sciatica Diseases 0.000 abstract description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 abstract description 2
- 231100000132 chronic toxicity testing Toxicity 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000759271 Alangium Species 0.000 abstract 1
- 241000218691 Cupressaceae Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 241000587240 Cynanchum Species 0.000 abstract 1
- 240000008955 Dioscorea japonica Species 0.000 abstract 1
- 235000005251 Dioscorea japonica Nutrition 0.000 abstract 1
- 241000292342 Dracaena cochinchinensis Species 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 244000082946 Tarchonanthus camphoratus Species 0.000 abstract 1
- 235000005701 Tarchonanthus camphoratus Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 5
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 206010056377 Bone tuberculosis Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 description 1
- 241000530704 Pachysandra axillaris Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for curing hyperosteogeny and rheumatism, in particular, it is a medicine extracted from natural plant. The medicine is a medicament prepared from the following raw materials in parts by weight: 60-80 parts of kusnezoff monkshood root, 0.2-0.5 part of Chinese alangium, 10-20 parts of Tongguan powder, 0.2-0.5 part of radix Anisodi Acutanguli, 5-15 parts of turmeric, 5-15 parts of Japanese yam, 5-15 parts of costus root, 5-15 parts of corydalis tuber, 5-15 parts of broom cypress fruit, 5-15 parts of dracaena cochinchinensis, 5-15 parts of erythrina indica, 4-7 parts of rhizoma paridis, 10-20 parts of cherokee rose fruit, 5-15 parts of cynanchum root, 5-15 parts of camphorwood and. Acute and chronic toxicity tests prove that the medicine has no toxic or side effect. The medicine of the invention is mainly used for treating various hyperosteogeny, rheumatoid arthritis, scapulohumeral periarthritis, sciatica, gout and lumbago.
Description
The present invention relates to a kind of treatment hyperosteogeny and rheumatismal medicine, especially with the medicine of extracted form natural plant.
Chinese patent application CN1073099A (application number 91111593) discloses a kind of " manufacture method of treatment hyperosteogeny pill ", it is characterized in that used herbal species and prescription are: Radix Angelicae Sinensis 5.0～9.0g, Radix Achyranthis Bidentatae 5.0～9.0g, give birth to Rhizoma Chuanxiong 50.0～80.0g, Radix Saposhnikoviae 25.0g, Radix Angelicae Dahuricae 50.0g, Radix Paeoniae Rubra 25.0～30.0g, Rhizoma Gastrodiae 25.0～30.0g, Flos Caryophylli 10.0～15.0g, Fructus Chaenomelis 50.0～60.0g, Rhizoma Et Radix Notopterygii 25.0～30.0g, Rhizoma Zingiberis 25.0～30.0g, Olibanum 10.0～15.0g, Myrrha 12.5～15.0g, Radix Aucklandiae (Radix Vladimiriae) 12.5～15.0g, Radix Aconiti Kusnezoffii 25.0～30.0g, Lignum Aquilariae Resinatum 12.5～15.0g, Cortex Cinnamomi 25.0～30.0g, its manufacturing process is for carrying out the infusion dried with Chinese medicine earlier, again through pulverizing, sieve, add sweet mixing and molding.
Chinese patent application CN1163755B (patent No. ZL96103823) discloses a kind of " injections of Chinese medicine of treatment rheumatic arthritis, hyperosteogeny and preparation method thereof ", it is characterized in that it is to be made by the following weight Chinese medicinal raw materials: Radix Paeoniae Alba 40-55 part Rhizoma Et Radix Notopterygii 10-25 part Rhizoma Chuanxiong 20-35 part Herba Asari 1-2 part.
The object of the present invention is to provide a kind of treatment hyperosteogeny, rheumatismal pure natural medical.
Medicine for treating osteoproliferation of the present invention is the medicament of being made by the following weight proportion raw material:
Radix Aconiti Kusnezoffii 60-80, Radix Alangii 0.2-0.5, TONGGUAN FEN 10-20, Radix Anisodi Acutanguli 0.2-0.5, Rhizoma Curcumae Longae 5-15, Prospiroboli joannsi 5-15, Radix Aucklandiae 5-15, Rhizoma Corydalis 5-15, Herba Lespedezae Cuneatae 5-15, Rhizoma Polygoni Paleachi 5-15, erythrina indica 5-15, Rhizoma Paridis 4-7, Fructus Rosae Laevigatae 10-20, Radix Heraclei Rapulae 5-15, Lignum cinnamomi camphorae 5-15, Radix Salviae Miltiorrhizae 10-20.
Also can add its weight proportion of Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) in above-mentioned medicament is 5-10, and its weight proportion of Pachysandra axillaris Franch. is 5-10.
Medicine of the present invention can be made said dosage form on any pharmaceutics.
Medicine of the present invention proves through acute and chronic toxicity test, has no side effect.Medicine of the present invention has the effect of relaxing muscles and tendons and activating QI and blood in the collateral, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, anti-inflammation detumescence, cure mainly all types of hyperosteogenys, rheumatic arthritis, rheumatoid, scapulohumeral periarthritis, sciatica, gout, lumbago, can treat also that wind myositis, cold hand and foot, bone tuberculosis, cerebral hemorrhage, cerebral infarction sequela, apoplectic hemiplegia, intervertebral disk hernia are deviate from, disease such as wound in the old.Through clinical verification, total effective rate reaches more than 90%.
Embodiment:
Get Radix Alangii 0.3 gram, TONGGUAN FEN 14 grams, Radix Anisodi Acutanguli 0.5 gram, Rhizoma Curcumae Longae 8 grams, Prospiroboli joannsi 7 grams, the Radix Aucklandiae 6 grams, Rhizoma Corydalis 10 grams, Herba Lespedezae Cuneatae 5 grams, Rhizoma Polygoni Paleachi 6 grams, erythrina indica 9 grams, Rhizoma Paridis 5 grams, Fructus Rosae Laevigatae 12 grams, Radix Heraclei Rapulae 10 grams, Lignum cinnamomi camphorae 8 grams, Radix Salviae Miltiorrhizae 15 grams.Clean, section is dried, and it is stand-by to make powdery.
Get Radix Aconiti Kusnezoffii 62 grams that dig autumn, boiled 2-3 hour with boiled water, section is dried, and breaks into powder behind the husky or fried bubble of reuse, adds above-mentioned stand-by medicated powder and mixes thoroughly and get final product.
Claims (1)
1, a kind of medicine for treating osteoproliferation is characterized in that it being the medicament of being made by the following weight proportion raw material: Radix Aconiti Kusnezoffii 60-80, Radix Alangii 0.2-0.5, TONGGUAN FEN 10-20, Radix Anisodi Acutanguli 0.2-0.5, Rhizoma Curcumae Longae 5-15, Prospiroboli joannsi 5-15, Radix Aucklandiae 5-15, Rhizoma Corydalis 5-15, Herba Lespedezae Cuneatae 5-15, Rhizoma Polygoni Paleachi 5-15, erythrina indica 5-15, Rhizoma Paridis 4-7, Fructus Rosae Laevigatae 10-20, Radix Heraclei Rapulae 5-15, Lignum cinnamomi camphorae 5-15, Radix Salviae Miltiorrhizae 10-20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021195552A CN1186056C (en) | 2002-05-24 | 2002-05-24 | medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021195552A CN1186056C (en) | 2002-05-24 | 2002-05-24 | medicine for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1459310A CN1459310A (en) | 2003-12-03 |
| CN1186056C true CN1186056C (en) | 2005-01-26 |
Family
ID=29426810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021195552A Expired - Fee Related CN1186056C (en) | 2002-05-24 | 2002-05-24 | medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1186056C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100337669C (en) * | 2005-08-17 | 2007-09-19 | 袁银龙 | Externally applied medicine for curing pain and process for preparing the same |
| CN101884652A (en) * | 2010-07-19 | 2010-11-17 | 唐宇龙 | Medicament for treating osteoproliferation |
| CN102512505B (en) * | 2011-11-29 | 2013-10-02 | 郑星有 | Chinese patent medicine for treating bone spur |
| CN103768200B (en) * | 2014-01-09 | 2016-04-20 | 汤伟杰 | A kind of Chinese herbal medicine granule for the treatment of hyperosteogeny and preparation method thereof |
-
2002
- 2002-05-24 CN CNB021195552A patent/CN1186056C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1459310A (en) | 2003-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1899535A (en) | Method for preparing dermopathic blood toxic capsule | |
| CN1204523A (en) | Prescription of dispelling wind and strengthening bone wine and preparation method | |
| CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN111840383A (en) | Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof | |
| CN103316192B (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN100366278C (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1186056C (en) | medicine for treating hyperosteogeny | |
| CN100381146C (en) | Traditional Chinese medicine for treating rheumatism | |
| CN101284084A (en) | Externally used Chinese medicine for curing hyperosteogeny and protrusion of lumbar intervertebral discs | |
| CN103341013B (en) | A kind of Chinese medicine for the treatment of lumbago and skelalgia | |
| CN100396316C (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN101099848A (en) | Traditional Chinese medicine powder agent for treating rheumatic arthritis, rheumatoid arthritis and ostealgia | |
| CN1071123C (en) | Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites | |
| CN101167864A (en) | Traditional Chinese medicinal formula for treating hyperosteogeny | |
| CN101337049A (en) | Production method of pills for treating rheumatoid, rheumatism and infantile paralysis | |
| CN1063650C (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1122520C (en) | Osteanaphysis capsule for treating femoral head necrosis | |
| CN1698801A (en) | Capsule for treating hemiplegia and rheumatism | |
| CN1457826A (en) | Capsule for killing pain and recovery | |
| CN1141953C (en) | Family handed traditional Chinese medicine recipe of osteomyelitis treatment | |
| CN1214920A (en) | Gucixiao pill for removing spur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20081212 Address after: No. 6 Fenghuang Road, Yunnan, Yuxi Patentee after: Wu Guifang Address before: No. 6 West Station Road, Yunnan, Yuxi Patentee before: Huang Benyun |
|
| ASS | Succession or assignment of patent right |
Owner name: WU GUIFANG Free format text: FORMER OWNER: HUANG BENYUN Effective date: 20081212 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050126 Termination date: 20170524 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |